Literature DB >> 16890022

Crossing cellular barriers using dendrimer nanotechnologies.

Mohammad Najlah1, Antony D'Emanuele.   

Abstract

Dendrimers represent a class of polymers characterised by their well-defined structure, with a high degree of molecular uniformity and low polydispersity. They have found a wide-range of pharmaceutical applications; however, more recently, they have been shown to function as effective intracellular carriers for drugs. In addition, dendrimers have been shown to be capable of bypassing efflux transporters. A new generation of dendrimer-based delivery systems will enable the efficient transport of drugs across cellular barriers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890022     DOI: 10.1016/j.coph.2006.05.004

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  15 in total

1.  Nanoparticle-macrophage interactions: A balance between clearance and cell-specific targeting.

Authors:  Rahul Rattan; Somnath Bhattacharjee; Hong Zong; Corban Swain; Muneeb A Siddiqui; Scott H Visovatti; Yogendra Kanthi; Sajani Desai; David J Pinsky; Sascha N Goonewardena
Journal:  Bioorg Med Chem       Date:  2017-06-30       Impact factor: 3.641

2.  Folate-Conjugated pH-Responsive Nanocarrier Designed for Active Tumor Targeting and Controlled Release of Gemcitabine.

Authors:  Ali Pourjavadi; Zahra Mazaheri Tehrani; Azardokht Abedin Moghanaki
Journal:  Pharm Res       Date:  2015-10-05       Impact factor: 4.200

3.  Modeling particle shape-dependent dynamics in nanomedicine.

Authors:  Samar Shah; Yaling Liu; Walter Hu; Jinming Gao
Journal:  J Nanosci Nanotechnol       Date:  2011-02

Review 4.  The shape of things to come: importance of design in nanotechnology for drug delivery.

Authors:  Yaling Liu; Jifu Tan; Antony Thomas; Daniel Ou-Yang; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2012-02

Review 5.  Nanoparticles in pregnancy: the next frontier in reproductive therapeutics.

Authors:  Natasha Pritchard; Tu'uhevaha Kaitu'u-Lino; Lynda Harris; Stephen Tong; Natalie Hannan
Journal:  Hum Reprod Update       Date:  2021-02-19       Impact factor: 17.179

6.  Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells.

Authors:  Samreen Khatri; Nandita G Das; Sudip K Das
Journal:  J Pharm Bioallied Sci       Date:  2014-10

7.  Synthesis of G0 aminopolyol and aminosugar dendrimers, controlled by NMR and MALDI TOF mass spectrometry.

Authors:  Mikołaj A Pyziak; Grażyna Bartkowiak; Łukasz Popenda; Stefan Jurga; Grzegorz Schroeder
Journal:  Des Monomers Polym       Date:  2016-10-14       Impact factor: 2.650

8.  Dendrimer-enabled transformation of Anaplasma phagocytophilum.

Authors:  Aminat T Oki; David Seidman; Michael G Lancina; Manoj K Mishra; Rangaramanujam M Kannan; Hu Yang; Jason A Carlyon
Journal:  Microbes Infect       Date:  2015-09-11       Impact factor: 9.570

9.  In vitro cytotoxicity of the ternary PAMAM G3-pyridoxal-biotin bioconjugate.

Authors:  Łukasz Uram; Magdalena Szuster; Krzysztof Gargasz; Aleksandra Filipowicz; Elżbieta Wałajtys-Rode; Stanisław Wołowiec
Journal:  Int J Nanomedicine       Date:  2013-12-11

10.  In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates.

Authors:  Mohammad Najlah; Sally Freeman; Mouhamad Khoder; David Attwood; Antony D'Emanuele
Journal:  Molecules       Date:  2017-10-04       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.